Inventor · disambiguated record
Jotham Wadsworth Coe
Also filed as: COE JOTHAM W · COE JOTHAM WADSWORTH
36 granted patents·30 pending applications·795 citations·filing 1983–2024
98Inventor score
Files withPFIZER55COE JOTHAM WADSWORTH1GILGAMESH PHARMACEUTICALS INC1KEY PHARMA1MCHARDY STANTON FURST1
Top patents by PatentIndex Score
66 records- 0197US4535157AProcess for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexoneKEY PHARMA·Filed 1983·Granted Aug 13, 1985·61 cites·3 claims
- 0296US6410550B1Aryl fused azapolycyclic compoundsPFIZER·Filed 1998·Granted Jun 25, 2002·134 cites·15 claims
- 0396US6130217ACompounds enhancing antitumor activity of other cytotoxic agentsPFIZER·Filed 1995·Granted Oct 10, 2000·181 cites·4 claims
- 0494US8895544B2IndazolesPFIZER LTD·Filed 2013·Granted Nov 25, 2014·43 cites·18 claims
- 0593US6605610B1Aryl fused azapolycyclic compoundsPFIZER·Filed 2000·Granted Aug 12, 2003·53 cites·3 claims
- 0692US8575336B2IndazolesCOE JOTHAM WADSWORTH·Filed 2012·Granted Nov 5, 2013·41 cites·13 claims
- 0790US9617258B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2014·Granted Apr 11, 2017·13 cites·6 claims
- 0890US7056930B22-Azabicyclo[3.3.1]nonane derivativesPFIZER·Filed 2004·Granted Jun 6, 2006·37 cites·22 claims
- 0988US9518052B2Pyrazolopyridines and pyrazolopyrimidinesPFIZER·Filed 2015·Granted Dec 13, 2016·8 cites·12 claims
- 1087US9617275B2Heteroaromatic compounds and their use as dopamine D1 ligandsPFIZER·Filed 2015·Granted Apr 11, 2017·5 cites·18 claims
- 1185US7241887B23-azabicyclo[3.2.1]octane derivativesPFIZER·Filed 2004·Granted Jul 10, 2007·35 cites·8 claims
- 1284US6951938B2Aryl fused azapolycyclic compoundsPFIZER·Filed 2002·Granted Oct 4, 2005·13 cites·14 claims
- 1384US6897310B2Aryl fused azapolycyclic compoundsPFIZER·Filed 2002·Granted May 24, 2005·13 cites·10 claims
- 1484US2025134869A1Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-midesPFIZER·Filed 2024·Application pending·0 cites
- 1583US7439236B2Pharmaceutical composition for the treatment of CNS and other disordersPFIZER·Filed 2006·Granted Oct 21, 2008·4 cites·10 claims
- 1683US7144882B2Aryl fused azapolycyclic compoundsPFIZER·Filed 2003·Granted Dec 5, 2006·16 cites·24 claims
- 1783US6887884B2Aryl fused azapolycyclic compoundsPFIZER·Filed 2002·Granted May 3, 2005·13 cites·16 claims
- 1882US5536722ATriazine derivatives for enhancing antitumor activityPFIZER·Filed 1992·Granted Jul 16, 1996·25 cites·14 claims
- 1981US10022376B2Pyrazolopyridines and pyrazolopyrimidinesPFIZER·Filed 2016·Granted Jul 17, 2018·3 cites·9 claims
- 2081US6881734B2Pharmaceutical composition for the treatment of CNS and other disordersPFIZER·Filed 2004·Granted Apr 19, 2005·11 cites·10 claims
- 2180US7205300B2Aryl fused azapolycyclic compoundsPFIZER·Filed 2003·Granted Apr 17, 2007·11 cites·24 claims
- 2280US5444062AQuinazolines derivatives for enhancing antitumor activityPFIZER·Filed 1991·Granted Aug 22, 1995·23 cites·27 claims
- 2378US6809094B2Pharmaceutical composition for the treatment of CNS and other disordersPFIZER·Filed 2002·Granted Oct 26, 2004·8 cites·13 claims
- 2476USRE40838E2-azabicyclo[3.3.1]nonane derivativesPFIZER·Filed 2007·Granted Jul 7, 2009·2 cites·22 claims
- 2573US12077533B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2021·Granted Sep 3, 2024·0 cites·2 claims
- 2666US7456177B2Heteroaryl fused azapolycyclic compoundsPFIZER·Filed 2004·Granted Nov 25, 2008·2 cites·3 claims
- 2765US11111242B2Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamidesPFIZER·Filed 2017·Granted Sep 7, 2021·0 cites·12 claims
- 2863US6080058AHood door airfoilPFIZER·Filed 1998·Granted Jun 27, 2000·19 cites·1 claims
- 2963US5491234APyrimidine derivatives for enhancing antitumor activityPFIZER·Filed 1992·Granted Feb 13, 1996·8 cites·14 claims
- 3063US2007275973A1Aryl fused azapolycyclic compoundsPFIZER·Filed 2007·Application pending·0 cites
- 3162US2017165270A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2017·Application pending·0 cites
- 3262US2015291625A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2013·Application pending·0 cites
- 3361US2025270173A1Pyridine derivatives for treating psychiatric disordersGILGAMESH PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3460US2018200253A1Heteroaromatic Compounds and their Use as Dopamine D1 LigandsPFIZER·Filed 2018·Application pending·0 cites
- 3558US2005176720A1Pharmaceutical composition for the treatment of CNS and other disordersPFIZER·Filed 2005·Application pending·0 cites
- 3657US2004220184A1Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)PFIZER·Filed 2004·Application pending·0 cites
- 3756US7122534B2Aryl fused azapolycyclic compoundsPFIZER·Filed 2004·Granted Oct 17, 2006·0 cites·9 claims
- 3856US5583137AHeterocyclic compounds for enhancing antitumor activityPFIZER·Filed 1992·Granted Dec 10, 1996·5 cites·10 claims
- 3954US6706702B2Aryl fused azapolycyclic compoundsPFIZER·Filed 2002·Granted Mar 16, 2004·0 cites·8 claims
- 4053US6462035B1Aryl fused azapolycyclic compoundsPFIZER·Filed 1999·Granted Oct 8, 2002·8 cites·10 claims
- 4153US2005043345A1Pharmaceutical composition for the prevention and treatment of addiction in a mammalPFIZER·Filed 2004·Application pending·0 cites
- 4253US2002086871A1Pharmaceutical composition for the treatment of CNS and other disordersFiled 2001·Application pending·0 cites
- 4352US2005032837A14-Phenyl-piperidine compounds and their use as modulators of opioid receptorsPFIZER·Filed 2004·Application pending·0 cites
- 4451US2004167200A1Pharmaceutical composition and method of modulating cholinergic function in a mammalPFIZER·Filed 2004·Application pending·0 cites
- 4551US2004204453A14-Phenyl-piperidine compounds and their use as modulators of opioid receptorsPFIZER·Filed 2004·Application pending·0 cites
- 4648US11312713B2Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitorsPFIZER·Filed 2018·Granted Apr 26, 2022·0 cites·18 claims
- 4747US2005020616A1Aryl fused azapolycyclic compoundsPFIZER·Filed 2004·Application pending·0 cites
- 4847US2002016334A1Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)Filed 2001·Application pending·0 cites
- 4947US2002010192A1Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight lossFiled 2001·Application pending·0 cites
- 5046US2003176457A1Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight lossPFIZER·Filed 2003·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jotham Wadsworth Coe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →